Cargando…
Residual Bioprosthetic Valve Immunogenicity: Forgotten, Not Lost
Despite early realization of the need to control inherent immunogenicity of bioprosthetic replacement heart valves and thereby mitigate the ensuing host response and its associated pathology, including dystrophic calcification, the problem remains unresolved to this day. Concerns over mechanical sti...
Autores principales: | Human, Paul, Bezuidenhout, Deon, Aikawa, Elena, Zilla, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764456/ https://www.ncbi.nlm.nih.gov/pubmed/35059444 http://dx.doi.org/10.3389/fcvm.2021.760635 |
Ejemplares similares
-
Long-Term Stability and Biocompatibility of Pericardial Bioprosthetic Heart Valves
por: Williams, David F., et al.
Publicado: (2021) -
Progressive Reinvention or Destination Lost? Half a Century of Cardiovascular Tissue Engineering
por: Zilla, Peter, et al.
Publicado: (2020) -
Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
por: Meng, Zhen, et al.
Publicado: (2021) -
Bioprosthetic valve monitoring in patients with carcinoid heart disease
por: Honan, Kevin A., et al.
Publicado: (2023) -
Frequency of Bioprosthetic Valve Fracturing Utilization in an All-Comers Valve-in-Valve TAVR Cohort
por: Ruge, Hendrik, et al.
Publicado: (2021)